nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—prostate cancer	0.115	0.519	CrCtD
Daunorubicin—Doxorubicin—prostate cancer	0.106	0.481	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—prostate cancer	0.0637	0.215	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Mitoxantrone—prostate cancer	0.0617	0.208	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—prostate cancer	0.059	0.199	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Etoposide—prostate cancer	0.0484	0.163	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—prostate cancer	0.0333	0.112	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—prostate cancer	0.0308	0.104	CiPCiCtD
Daunorubicin—TOP2A—prostate cancer	0.027	0.273	CbGaD
Daunorubicin—CYP1B1—prostate cancer	0.0268	0.271	CbGaD
Daunorubicin—Valrubicin—Epirubicin—prostate cancer	0.0244	0.173	CrCrCtD
Daunorubicin—Doxorubicin—Epirubicin—prostate cancer	0.0244	0.173	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—prostate cancer	0.0244	0.173	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—prostate cancer	0.0225	0.16	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—prostate cancer	0.0225	0.16	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—prostate cancer	0.0225	0.16	CrCrCtD
Daunorubicin—CYP3A5—prostate cancer	0.0213	0.216	CbGaD
Daunorubicin—POR—Nilutamide—prostate cancer	0.0192	0.117	CbGbCtD
Daunorubicin—CYP1A1—prostate cancer	0.0145	0.146	CbGaD
Daunorubicin—YWHAG—Epirubicin—prostate cancer	0.0134	0.0812	CbGbCtD
Daunorubicin—TOP2B—Etoposide—prostate cancer	0.0104	0.0632	CbGbCtD
Daunorubicin—CYP3A4—prostate cancer	0.00923	0.0934	CbGaD
Daunorubicin—YWHAG—Doxorubicin—prostate cancer	0.0071	0.0431	CbGbCtD
Daunorubicin—CYP1B1—Flutamide—prostate cancer	0.00608	0.037	CbGbCtD
Daunorubicin—ABCC10—Estradiol—prostate cancer	0.00465	0.0282	CbGbCtD
Daunorubicin—CYP1B1—Estrone—prostate cancer	0.0044	0.0267	CbGbCtD
Daunorubicin—ABCC1—Abiraterone—prostate cancer	0.00432	0.0263	CbGbCtD
Daunorubicin—ABCC6—Etoposide—prostate cancer	0.00397	0.0241	CbGbCtD
Daunorubicin—ABCB11—Ethinyl Estradiol—prostate cancer	0.00392	0.0238	CbGbCtD
Daunorubicin—TOP2A—Mitoxantrone—prostate cancer	0.00335	0.0204	CbGbCtD
Daunorubicin—ABCC10—Etoposide—prostate cancer	0.00303	0.0184	CbGbCtD
Daunorubicin—POR—Doxorubicin—prostate cancer	0.00295	0.0179	CbGbCtD
Daunorubicin—ABCC10—Docetaxel—prostate cancer	0.00278	0.0169	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—prostate cancer	0.00271	0.0165	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—prostate cancer	0.00271	0.0165	CbGbCtD
Daunorubicin—CYP1A1—Flutamide—prostate cancer	0.00267	0.0162	CbGbCtD
Daunorubicin—CYP1B1—Mitoxantrone—prostate cancer	0.00262	0.0159	CbGbCtD
Daunorubicin—CYP1B1—Estradiol—prostate cancer	0.00253	0.0154	CbGbCtD
Daunorubicin—ABCG2—Cabazitaxel—prostate cancer	0.00214	0.013	CbGbCtD
Daunorubicin—TOP2A—Etoposide—prostate cancer	0.00211	0.0128	CbGbCtD
Daunorubicin—ABCG2—Estrone—prostate cancer	0.00209	0.0127	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—prostate cancer	0.00207	0.0126	CbGbCtD
Daunorubicin—ABCC2—Ethinyl Estradiol—prostate cancer	0.00206	0.0125	CbGbCtD
Daunorubicin—ABCC1—Conjugated Estrogens—prostate cancer	0.00204	0.0124	CbGbCtD
Daunorubicin—CYP1A1—Estrone—prostate cancer	0.00193	0.0117	CbGbCtD
Daunorubicin—ABCC1—Mitoxantrone—prostate cancer	0.00186	0.0113	CbGbCtD
Daunorubicin—XDH—Doxorubicin—prostate cancer	0.00169	0.0103	CbGbCtD
Daunorubicin—SLC22A2—Estradiol—prostate cancer	0.00163	0.00989	CbGbCtD
Daunorubicin—CYP3A5—Flutamide—prostate cancer	0.0016	0.00974	CbGbCtD
Daunorubicin—ABCC2—Conjugated Estrogens—prostate cancer	0.00151	0.00919	CbGbCtD
Daunorubicin—CYP1B1—Docetaxel—prostate cancer	0.00151	0.00917	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—prostate cancer	0.0015	0.00914	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—prostate cancer	0.00144	0.00876	CbGbCtD
Daunorubicin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00144	0.00872	CbGbCtD
Daunorubicin—ABCG2—Conjugated Estrogens—prostate cancer	0.00137	0.00831	CbGbCtD
Daunorubicin—ABCG2—Mitoxantrone—prostate cancer	0.00124	0.00756	CbGbCtD
Daunorubicin—ABCG2—Estradiol—prostate cancer	0.0012	0.0073	CbGbCtD
Daunorubicin—CYP1A2—Flutamide—prostate cancer	0.00119	0.00725	CbGbCtD
Daunorubicin—CYP3A5—Cabazitaxel—prostate cancer	0.00119	0.0072	CbGbCtD
Daunorubicin—ABCC1—Etoposide—prostate cancer	0.00117	0.00712	CbGbCtD
Daunorubicin—ABCB1—Estramustine—prostate cancer	0.00117	0.00711	CbGbCtD
Daunorubicin—CYP3A5—Estrone—prostate cancer	0.00116	0.00704	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—prostate cancer	0.00113	0.00684	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—prostate cancer	0.00113	0.00684	CbGbCtD
Daunorubicin—CYP1A1—Estradiol—prostate cancer	0.00111	0.00674	CbGbCtD
Daunorubicin—ABCC1—Docetaxel—prostate cancer	0.00107	0.00652	CbGbCtD
Daunorubicin—ABCC2—Etoposide—prostate cancer	0.000867	0.00527	CbGbCtD
Daunorubicin—CYP1A2—Estrone—prostate cancer	0.000862	0.00524	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—prostate cancer	0.000799	0.00486	CbGbCtD
Daunorubicin—ABCC2—Docetaxel—prostate cancer	0.000794	0.00482	CbGbCtD
Daunorubicin—ABCG2—Etoposide—prostate cancer	0.000784	0.00477	CbGbCtD
Daunorubicin—ABCB1—Cabazitaxel—prostate cancer	0.000771	0.00469	CbGbCtD
Daunorubicin—CYP3A4—Bicalutamide—prostate cancer	0.000754	0.00458	CbGbCtD
Daunorubicin—ABCB1—Estrone—prostate cancer	0.000754	0.00458	CbGbCtD
Daunorubicin—ABCG2—Docetaxel—prostate cancer	0.000717	0.00436	CbGbCtD
Daunorubicin—CYP3A4—Estramustine—prostate cancer	0.000701	0.00426	CbGbCtD
Daunorubicin—ABCB1—Ethinyl Estradiol—prostate cancer	0.000672	0.00408	CbGbCtD
Daunorubicin—CYP3A5—Estradiol—prostate cancer	0.000665	0.00404	CbGbCtD
Daunorubicin—CYP3A4—Abiraterone—prostate cancer	0.000625	0.0038	CbGbCtD
Daunorubicin—CYP3A4—Flutamide—prostate cancer	0.000625	0.0038	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—prostate cancer	0.000592	0.0036	CbGbCtD
Daunorubicin—CYP1A2—Conjugated Estrogens—prostate cancer	0.000564	0.00343	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—prostate cancer	0.000535	0.00325	CbGbCtD
Daunorubicin—CYP1A2—Estradiol—prostate cancer	0.000495	0.00301	CbGbCtD
Daunorubicin—ABCB1—Conjugated Estrogens—prostate cancer	0.000493	0.003	CbGbCtD
Daunorubicin—CYP3A4—Cabazitaxel—prostate cancer	0.000462	0.00281	CbGbCtD
Daunorubicin—CYP3A4—Estrone—prostate cancer	0.000452	0.00275	CbGbCtD
Daunorubicin—ABCB1—Mitoxantrone—prostate cancer	0.000448	0.00272	CbGbCtD
Daunorubicin—CYP3A5—Etoposide—prostate cancer	0.000434	0.00264	CbGbCtD
Daunorubicin—ABCB1—Estradiol—prostate cancer	0.000433	0.00263	CbGbCtD
Daunorubicin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000403	0.00245	CbGbCtD
Daunorubicin—CYP3A5—Docetaxel—prostate cancer	0.000397	0.00242	CbGbCtD
Daunorubicin—ABCB1—Prednisone—prostate cancer	0.000372	0.00226	CbGbCtD
Daunorubicin—YWHAG—prostate gland—prostate cancer	0.000368	0.0341	CbGeAlD
Daunorubicin—XDH—prostate gland—prostate cancer	0.000359	0.0333	CbGeAlD
Daunorubicin—TOP2B—prostate gland—prostate cancer	0.000355	0.0329	CbGeAlD
Daunorubicin—CYP1A2—urine—prostate cancer	0.000349	0.0323	CbGeAlD
Daunorubicin—CYP1A2—Etoposide—prostate cancer	0.000323	0.00197	CbGbCtD
Daunorubicin—YWHAG—seminal vesicle—prostate cancer	0.000312	0.0288	CbGeAlD
Daunorubicin—TOP2B—seminal vesicle—prostate cancer	0.0003	0.0278	CbGeAlD
Daunorubicin—CYP3A4—Conjugated Estrogens—prostate cancer	0.000296	0.0018	CbGbCtD
Daunorubicin—ABCB1—Etoposide—prostate cancer	0.000283	0.00172	CbGbCtD
Daunorubicin—POR—prostate gland—prostate cancer	0.00028	0.0259	CbGeAlD
Daunorubicin—CYP3A4—Mitoxantrone—prostate cancer	0.000269	0.00163	CbGbCtD
Daunorubicin—ABCC6—renal system—prostate cancer	0.000267	0.0247	CbGeAlD
Daunorubicin—TOP2A—prostate gland—prostate cancer	0.000261	0.0242	CbGeAlD
Daunorubicin—CYP3A4—Estradiol—prostate cancer	0.000259	0.00158	CbGbCtD
Daunorubicin—ABCB1—Docetaxel—prostate cancer	0.000259	0.00157	CbGbCtD
Daunorubicin—CYP3A4—urine—prostate cancer	0.000253	0.0234	CbGeAlD
Daunorubicin—YWHAG—renal system—prostate cancer	0.000251	0.0232	CbGeAlD
Daunorubicin—YWHAG—urethra—prostate cancer	0.000247	0.0228	CbGeAlD
Daunorubicin—NR5A1—testis—prostate cancer	0.000246	0.0227	CbGeAlD
Daunorubicin—XDH—renal system—prostate cancer	0.000245	0.0227	CbGeAlD
Daunorubicin—TOP2B—renal system—prostate cancer	0.000242	0.0224	CbGeAlD
Daunorubicin—TOP2B—urethra—prostate cancer	0.000238	0.022	CbGeAlD
Daunorubicin—POR—seminal vesicle—prostate cancer	0.000237	0.0219	CbGeAlD
Daunorubicin—CYP3A4—Prednisone—prostate cancer	0.000223	0.00136	CbGbCtD
Daunorubicin—ABCC10—prostate gland—prostate cancer	0.000222	0.0206	CbGeAlD
Daunorubicin—ABCB1—Doxorubicin—prostate cancer	0.000193	0.00117	CbGbCtD
Daunorubicin—SLC22A2—renal system—prostate cancer	0.000192	0.0178	CbGeAlD
Daunorubicin—YWHAG—bone marrow—prostate cancer	0.00019	0.0176	CbGeAlD
Daunorubicin—ABCC10—seminal vesicle—prostate cancer	0.000188	0.0174	CbGeAlD
Daunorubicin—POR—urethra—prostate cancer	0.000188	0.0174	CbGeAlD
Daunorubicin—TOP2B—bone marrow—prostate cancer	0.000183	0.0169	CbGeAlD
Daunorubicin—Epirubicin—AURKA—prostate cancer	0.00018	0.15	CrCbGaD
Daunorubicin—ABCC2—prostate gland—prostate cancer	0.000178	0.0165	CbGeAlD
Daunorubicin—CYP1B1—prostate gland—prostate cancer	0.000175	0.0162	CbGeAlD
Daunorubicin—Doxorubicin—CBR1—prostate cancer	0.000173	0.144	CrCbGaD
Daunorubicin—CYP3A4—Etoposide—prostate cancer	0.000169	0.00103	CbGbCtD
Daunorubicin—Valrubicin—TOP2A—prostate cancer	0.000166	0.139	CrCbGaD
Daunorubicin—YWHAG—testis—prostate cancer	0.000162	0.015	CbGeAlD
Daunorubicin—ABCC1—prostate gland—prostate cancer	0.000157	0.0146	CbGeAlD
Daunorubicin—TOP2B—testis—prostate cancer	0.000156	0.0145	CbGeAlD
Daunorubicin—CYP3A4—Docetaxel—prostate cancer	0.000155	0.000942	CbGbCtD
Daunorubicin—ABCB11—testis—prostate cancer	0.000155	0.0143	CbGeAlD
Daunorubicin—ABCC10—renal system—prostate cancer	0.000152	0.014	CbGeAlD
Daunorubicin—ABCC10—urethra—prostate cancer	0.000149	0.0138	CbGeAlD
Daunorubicin—POR—bone marrow—prostate cancer	0.000144	0.0134	CbGeAlD
Daunorubicin—TOP2B—Teniposide—Etoposide—prostate cancer	0.000135	0.199	CbGdCrCtD
Daunorubicin—TOP2A—bone marrow—prostate cancer	0.000135	0.0125	CbGeAlD
Daunorubicin—ABCC1—seminal vesicle—prostate cancer	0.000133	0.0123	CbGeAlD
Daunorubicin—ABCG2—prostate gland—prostate cancer	0.00013	0.012	CbGeAlD
Daunorubicin—POR—testis—prostate cancer	0.000123	0.0114	CbGeAlD
Daunorubicin—Doxorubicin—RALBP1—prostate cancer	0.000122	0.102	CrCbGaD
Daunorubicin—ABCC2—renal system—prostate cancer	0.000122	0.0113	CbGeAlD
Daunorubicin—CYP3A5—prostate gland—prostate cancer	0.000121	0.0112	CbGeAlD
Daunorubicin—ABCC6—Podofilox—Etoposide—prostate cancer	0.00012	0.178	CbGdCrCtD
Daunorubicin—CYP1B1—renal system—prostate cancer	0.000119	0.011	CbGeAlD
Daunorubicin—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000118	0.175	CbGdCrCtD
Daunorubicin—YWHAG—lymph node—prostate cancer	0.000118	0.0109	CbGeAlD
Daunorubicin—CYP3A4—Doxorubicin—prostate cancer	0.000116	0.000702	CbGbCtD
Daunorubicin—TOP2A—testis—prostate cancer	0.000115	0.0106	CbGeAlD
Daunorubicin—ABCC10—bone marrow—prostate cancer	0.000115	0.0106	CbGeAlD
Daunorubicin—TOP2B—lymph node—prostate cancer	0.000113	0.0105	CbGeAlD
Daunorubicin—ABCG2—seminal vesicle—prostate cancer	0.00011	0.0102	CbGeAlD
Daunorubicin—ABCC1—urethra—prostate cancer	0.000105	0.00974	CbGeAlD
Daunorubicin—Doxorubicin—AURKA—prostate cancer	0.000103	0.0864	CrCbGaD
Daunorubicin—ABCC10—testis—prostate cancer	9.79e-05	0.00906	CbGeAlD
Daunorubicin—Idarubicin—TOP2A—prostate cancer	9.55e-05	0.0797	CrCbGaD
Daunorubicin—CYP1A1—epithelium—prostate cancer	9.08e-05	0.0084	CbGeAlD
Daunorubicin—POR—lymph node—prostate cancer	8.95e-05	0.00828	CbGeAlD
Daunorubicin—ABCG2—urethra—prostate cancer	8.71e-05	0.00807	CbGeAlD
Daunorubicin—CYP1A2—renal system—prostate cancer	8.54e-05	0.0079	CbGeAlD
Daunorubicin—CYP1A1—renal system—prostate cancer	8.42e-05	0.0078	CbGeAlD
Daunorubicin—TOP2A—lymph node—prostate cancer	8.34e-05	0.00772	CbGeAlD
Daunorubicin—CYP1A1—urethra—prostate cancer	8.27e-05	0.00766	CbGeAlD
Daunorubicin—CYP3A5—renal system—prostate cancer	8.24e-05	0.00762	CbGeAlD
Daunorubicin—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	8.18e-05	0.121	CbGdCrCtD
Daunorubicin—Doxorubicin—AKR1C3—prostate cancer	7.93e-05	0.0662	CrCbGaD
Daunorubicin—ABCC2—testis—prostate cancer	7.86e-05	0.00728	CbGeAlD
Daunorubicin—CYP1B1—testis—prostate cancer	7.7e-05	0.00713	CbGeAlD
Daunorubicin—Epirubicin—TOP2A—prostate cancer	7.24e-05	0.0604	CrCbGaD
Daunorubicin—ABCC10—lymph node—prostate cancer	7.1e-05	0.00657	CbGeAlD
Daunorubicin—ABCC1—testis—prostate cancer	6.93e-05	0.00641	CbGeAlD
Daunorubicin—ABCG2—bone marrow—prostate cancer	6.71e-05	0.00621	CbGeAlD
Daunorubicin—ABCB1—prostate gland—prostate cancer	6.42e-05	0.00594	CbGeAlD
Daunorubicin—CYP3A4—renal system—prostate cancer	6.18e-05	0.00572	CbGeAlD
Daunorubicin—Doxorubicin—NQO1—prostate cancer	5.94e-05	0.0496	CrCbGaD
Daunorubicin—ABCG2—testis—prostate cancer	5.73e-05	0.00531	CbGeAlD
Daunorubicin—ABCC2—lymph node—prostate cancer	5.7e-05	0.00528	CbGeAlD
Daunorubicin—CYP1B1—lymph node—prostate cancer	5.58e-05	0.00517	CbGeAlD
Daunorubicin—ABCB1—seminal vesicle—prostate cancer	5.43e-05	0.00503	CbGeAlD
Daunorubicin—ABCC1—lymph node—prostate cancer	5.02e-05	0.00465	CbGeAlD
Daunorubicin—Doxorubicin—NOS3—prostate cancer	5.02e-05	0.0419	CrCbGaD
Daunorubicin—ABCB1—epithelium—prostate cancer	4.72e-05	0.00437	CbGeAlD
Daunorubicin—ABCB1—renal system—prostate cancer	4.37e-05	0.00405	CbGeAlD
Daunorubicin—ABCB1—urethra—prostate cancer	4.3e-05	0.00398	CbGeAlD
Daunorubicin—ABCG2—lymph node—prostate cancer	4.16e-05	0.00385	CbGeAlD
Daunorubicin—Doxorubicin—TOP2A—prostate cancer	4.16e-05	0.0347	CrCbGaD
Daunorubicin—Doxorubicin—CYP1B1—prostate cancer	4.12e-05	0.0344	CrCbGaD
Daunorubicin—CYP1A1—lymph node—prostate cancer	3.95e-05	0.00365	CbGeAlD
Daunorubicin—TOP2A—Paclitaxel—Docetaxel—prostate cancer	3.39e-05	0.0501	CbGdCrCtD
Daunorubicin—ABCB1—bone marrow—prostate cancer	3.31e-05	0.00306	CbGeAlD
Daunorubicin—ABCB1—testis—prostate cancer	2.83e-05	0.00262	CbGeAlD
Daunorubicin—TOP2A—Fulvestrant—Estradiol—prostate cancer	2.48e-05	0.0366	CbGdCrCtD
Daunorubicin—TOP2A—Teniposide—Etoposide—prostate cancer	2.18e-05	0.0322	CbGdCrCtD
Daunorubicin—TOP2A—Podofilox—Etoposide—prostate cancer	2.18e-05	0.0322	CbGdCrCtD
Daunorubicin—TOP2A—Levorphanol—Estrone—prostate cancer	2.16e-05	0.0319	CbGdCrCtD
Daunorubicin—ABCB1—lymph node—prostate cancer	2.05e-05	0.0019	CbGeAlD
Daunorubicin—TOP2A—Levorphanol—Estradiol—prostate cancer	1.64e-05	0.0242	CbGdCrCtD
Daunorubicin—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	1.49e-05	0.0221	CbGdCrCtD
Daunorubicin—Doxorubicin—CYP3A4—prostate cancer	1.42e-05	0.0119	CrCbGaD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—prostate cancer	1.14e-05	0.0168	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—prostate cancer	1.14e-05	0.0168	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—prostate cancer	1.05e-05	0.0155	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—prostate cancer	1.05e-05	0.0155	CbGdCrCtD
Daunorubicin—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	9.74e-06	0.0144	CbGdCrCtD
Daunorubicin—Discomfort—Capecitabine—prostate cancer	8.8e-06	0.000235	CcSEcCtD
Daunorubicin—Infection—Docetaxel—prostate cancer	8.76e-06	0.000234	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—prostate cancer	8.75e-06	0.000234	CcSEcCtD
Daunorubicin—Feeling abnormal—Etoposide—prostate cancer	8.74e-06	0.000234	CcSEcCtD
Daunorubicin—Diarrhoea—Mitoxantrone—prostate cancer	8.73e-06	0.000233	CcSEcCtD
Daunorubicin—Dry mouth—Capecitabine—prostate cancer	8.71e-06	0.000233	CcSEcCtD
Daunorubicin—Vomiting—Estradiol—prostate cancer	8.7e-06	0.000233	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Etoposide—prostate cancer	8.68e-06	0.000232	CcSEcCtD
Daunorubicin—Shock—Docetaxel—prostate cancer	8.68e-06	0.000232	CcSEcCtD
Daunorubicin—Ill-defined disorder—Prednisone—prostate cancer	8.65e-06	0.000231	CcSEcCtD
Daunorubicin—Thrombocytopenia—Docetaxel—prostate cancer	8.63e-06	0.000231	CcSEcCtD
Daunorubicin—Rash—Estradiol—prostate cancer	8.63e-06	0.000231	CcSEcCtD
Daunorubicin—Dermatitis—Estradiol—prostate cancer	8.62e-06	0.000231	CcSEcCtD
Daunorubicin—Anaemia—Prednisone—prostate cancer	8.61e-06	0.00023	CcSEcCtD
Daunorubicin—Confusional state—Capecitabine—prostate cancer	8.61e-06	0.00023	CcSEcCtD
Daunorubicin—Tachycardia—Docetaxel—prostate cancer	8.61e-06	0.00023	CcSEcCtD
Daunorubicin—Headache—Estradiol—prostate cancer	8.58e-06	0.000229	CcSEcCtD
Daunorubicin—Agitation—Prednisone—prostate cancer	8.56e-06	0.000229	CcSEcCtD
Daunorubicin—Oedema—Capecitabine—prostate cancer	8.54e-06	0.000228	CcSEcCtD
Daunorubicin—Renal failure—Doxorubicin—prostate cancer	8.48e-06	0.000227	CcSEcCtD
Daunorubicin—Infection—Capecitabine—prostate cancer	8.48e-06	0.000227	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—prostate cancer	8.46e-06	0.000226	CcSEcCtD
Daunorubicin—Urticaria—Etoposide—prostate cancer	8.43e-06	0.000225	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—prostate cancer	8.41e-06	0.000225	CcSEcCtD
Daunorubicin—Anorexia—Docetaxel—prostate cancer	8.41e-06	0.000225	CcSEcCtD
Daunorubicin—Malaise—Prednisone—prostate cancer	8.4e-06	0.000225	CcSEcCtD
Daunorubicin—Shock—Capecitabine—prostate cancer	8.4e-06	0.000225	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—prostate cancer	8.39e-06	0.000224	CcSEcCtD
Daunorubicin—Abdominal pain—Etoposide—prostate cancer	8.39e-06	0.000224	CcSEcCtD
Daunorubicin—Body temperature increased—Etoposide—prostate cancer	8.39e-06	0.000224	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—prostate cancer	8.39e-06	0.000224	CcSEcCtD
Daunorubicin—Thrombocytopenia—Capecitabine—prostate cancer	8.36e-06	0.000224	CcSEcCtD
Daunorubicin—Syncope—Prednisone—prostate cancer	8.36e-06	0.000224	CcSEcCtD
Daunorubicin—Tachycardia—Capecitabine—prostate cancer	8.33e-06	0.000223	CcSEcCtD
Daunorubicin—Hyperhidrosis—Capecitabine—prostate cancer	8.25e-06	0.000221	CcSEcCtD
Daunorubicin—Loss of consciousness—Prednisone—prostate cancer	8.19e-06	0.000219	CcSEcCtD
Daunorubicin—Anorexia—Capecitabine—prostate cancer	8.14e-06	0.000218	CcSEcCtD
Daunorubicin—Nausea—Estradiol—prostate cancer	8.13e-06	0.000218	CcSEcCtD
Daunorubicin—Vomiting—Mitoxantrone—prostate cancer	8.11e-06	0.000217	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—prostate cancer	8.1e-06	0.000217	CcSEcCtD
Daunorubicin—Convulsion—Prednisone—prostate cancer	8.07e-06	0.000216	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—prostate cancer	8.07e-06	0.000216	CcSEcCtD
Daunorubicin—Hypertension—Prednisone—prostate cancer	8.04e-06	0.000215	CcSEcCtD
Daunorubicin—Rash—Mitoxantrone—prostate cancer	8.04e-06	0.000215	CcSEcCtD
Daunorubicin—Dermatitis—Mitoxantrone—prostate cancer	8.04e-06	0.000215	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.03e-06	0.000215	CcSEcCtD
Daunorubicin—Headache—Mitoxantrone—prostate cancer	7.99e-06	0.000214	CcSEcCtD
Daunorubicin—Insomnia—Docetaxel—prostate cancer	7.98e-06	0.000213	CcSEcCtD
Daunorubicin—Myalgia—Prednisone—prostate cancer	7.93e-06	0.000212	CcSEcCtD
Daunorubicin—Arthralgia—Prednisone—prostate cancer	7.93e-06	0.000212	CcSEcCtD
Daunorubicin—Anxiety—Prednisone—prostate cancer	7.91e-06	0.000211	CcSEcCtD
Daunorubicin—Dyspnoea—Docetaxel—prostate cancer	7.86e-06	0.00021	CcSEcCtD
Daunorubicin—Somnolence—Docetaxel—prostate cancer	7.84e-06	0.00021	CcSEcCtD
Daunorubicin—Discomfort—Prednisone—prostate cancer	7.84e-06	0.00021	CcSEcCtD
Daunorubicin—Hypersensitivity—Etoposide—prostate cancer	7.82e-06	0.000209	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—prostate cancer	7.81e-06	0.000209	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.78e-06	0.000208	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—prostate cancer	7.77e-06	0.000208	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—prostate cancer	7.77e-06	0.000208	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—prostate cancer	7.77e-06	0.000208	CcSEcCtD
Daunorubicin—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	7.75e-06	0.0114	CbGdCrCtD
Daunorubicin—Insomnia—Capecitabine—prostate cancer	7.72e-06	0.000207	CcSEcCtD
Daunorubicin—Decreased appetite—Docetaxel—prostate cancer	7.67e-06	0.000205	CcSEcCtD
Daunorubicin—Asthenia—Etoposide—prostate cancer	7.61e-06	0.000204	CcSEcCtD
Daunorubicin—Dyspnoea—Capecitabine—prostate cancer	7.61e-06	0.000204	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisone—prostate cancer	7.6e-06	0.000203	CcSEcCtD
Daunorubicin—Oedema—Prednisone—prostate cancer	7.6e-06	0.000203	CcSEcCtD
Daunorubicin—Fatigue—Docetaxel—prostate cancer	7.6e-06	0.000203	CcSEcCtD
Daunorubicin—Nausea—Mitoxantrone—prostate cancer	7.58e-06	0.000203	CcSEcCtD
Daunorubicin—Infection—Prednisone—prostate cancer	7.56e-06	0.000202	CcSEcCtD
Daunorubicin—Constipation—Docetaxel—prostate cancer	7.54e-06	0.000202	CcSEcCtD
Daunorubicin—Pain—Docetaxel—prostate cancer	7.54e-06	0.000202	CcSEcCtD
Daunorubicin—Chills—Epirubicin—prostate cancer	7.51e-06	0.000201	CcSEcCtD
Daunorubicin—Pruritus—Etoposide—prostate cancer	7.51e-06	0.000201	CcSEcCtD
Daunorubicin—Shock—Prednisone—prostate cancer	7.48e-06	0.0002	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—prostate cancer	7.48e-06	0.0002	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—prostate cancer	7.46e-06	0.0002	CcSEcCtD
Daunorubicin—Tachycardia—Prednisone—prostate cancer	7.42e-06	0.000199	CcSEcCtD
Daunorubicin—Decreased appetite—Capecitabine—prostate cancer	7.42e-06	0.000199	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—prostate cancer	7.4e-06	0.000198	CcSEcCtD
Daunorubicin—Fatigue—Capecitabine—prostate cancer	7.36e-06	0.000197	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisone—prostate cancer	7.35e-06	0.000197	CcSEcCtD
Daunorubicin—Constipation—Capecitabine—prostate cancer	7.3e-06	0.000195	CcSEcCtD
Daunorubicin—Pain—Capecitabine—prostate cancer	7.3e-06	0.000195	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—prostate cancer	7.29e-06	0.000195	CcSEcCtD
Daunorubicin—Feeling abnormal—Docetaxel—prostate cancer	7.27e-06	0.000194	CcSEcCtD
Daunorubicin—Diarrhoea—Etoposide—prostate cancer	7.26e-06	0.000194	CcSEcCtD
Daunorubicin—Anorexia—Prednisone—prostate cancer	7.25e-06	0.000194	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—prostate cancer	7.22e-06	0.000193	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Docetaxel—prostate cancer	7.21e-06	0.000193	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—prostate cancer	7.19e-06	0.000192	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—prostate cancer	7.19e-06	0.000192	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—prostate cancer	7.14e-06	0.000191	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—prostate cancer	7.05e-06	0.000189	CcSEcCtD
Daunorubicin—Feeling abnormal—Capecitabine—prostate cancer	7.04e-06	0.000188	CcSEcCtD
Daunorubicin—Dizziness—Etoposide—prostate cancer	7.02e-06	0.000188	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Capecitabine—prostate cancer	6.98e-06	0.000187	CcSEcCtD
Daunorubicin—Abdominal pain—Docetaxel—prostate cancer	6.97e-06	0.000186	CcSEcCtD
Daunorubicin—Body temperature increased—Docetaxel—prostate cancer	6.97e-06	0.000186	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—prostate cancer	6.95e-06	0.000186	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Prednisone—prostate cancer	6.93e-06	0.000185	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—prostate cancer	6.92e-06	0.000185	CcSEcCtD
Daunorubicin—Insomnia—Prednisone—prostate cancer	6.88e-06	0.000184	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—prostate cancer	6.85e-06	0.000183	CcSEcCtD
Daunorubicin—Urticaria—Capecitabine—prostate cancer	6.78e-06	0.000181	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—prostate cancer	6.76e-06	0.000181	CcSEcCtD
Daunorubicin—Abdominal pain—Capecitabine—prostate cancer	6.75e-06	0.000181	CcSEcCtD
Daunorubicin—Body temperature increased—Capecitabine—prostate cancer	6.75e-06	0.000181	CcSEcCtD
Daunorubicin—Vomiting—Etoposide—prostate cancer	6.75e-06	0.00018	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—prostate cancer	6.74e-06	0.00018	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—prostate cancer	6.74e-06	0.00018	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—prostate cancer	6.7e-06	0.000179	CcSEcCtD
Daunorubicin—Rash—Etoposide—prostate cancer	6.69e-06	0.000179	CcSEcCtD
Daunorubicin—Dermatitis—Etoposide—prostate cancer	6.68e-06	0.000179	CcSEcCtD
Daunorubicin—Headache—Etoposide—prostate cancer	6.65e-06	0.000178	CcSEcCtD
Daunorubicin—Decreased appetite—Prednisone—prostate cancer	6.61e-06	0.000177	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—prostate cancer	6.6e-06	0.000177	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—prostate cancer	6.57e-06	0.000176	CcSEcCtD
Daunorubicin—Fatigue—Prednisone—prostate cancer	6.56e-06	0.000175	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—prostate cancer	6.54e-06	0.000175	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—prostate cancer	6.52e-06	0.000174	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—prostate cancer	6.52e-06	0.000174	CcSEcCtD
Daunorubicin—Constipation—Prednisone—prostate cancer	6.5e-06	0.000174	CcSEcCtD
Daunorubicin—Hypersensitivity—Docetaxel—prostate cancer	6.5e-06	0.000174	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—prostate cancer	6.44e-06	0.000172	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—prostate cancer	6.41e-06	0.000171	CcSEcCtD
Daunorubicin—Cough—Epirubicin—prostate cancer	6.36e-06	0.00017	CcSEcCtD
Daunorubicin—Asthenia—Docetaxel—prostate cancer	6.33e-06	0.000169	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—prostate cancer	6.31e-06	0.000169	CcSEcCtD
Daunorubicin—Nausea—Etoposide—prostate cancer	6.3e-06	0.000169	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—prostate cancer	6.29e-06	0.000168	CcSEcCtD
Daunorubicin—Hypersensitivity—Capecitabine—prostate cancer	6.29e-06	0.000168	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisone—prostate cancer	6.27e-06	0.000168	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—prostate cancer	6.26e-06	0.000167	CcSEcCtD
Daunorubicin—Pruritus—Docetaxel—prostate cancer	6.24e-06	0.000167	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—prostate cancer	6.23e-06	0.000167	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Prednisone—prostate cancer	6.22e-06	0.000166	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—prostate cancer	6.2e-06	0.000166	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—prostate cancer	6.2e-06	0.000166	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—prostate cancer	6.2e-06	0.000166	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—prostate cancer	6.2e-06	0.000166	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—prostate cancer	6.18e-06	0.000165	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—prostate cancer	6.13e-06	0.000164	CcSEcCtD
Daunorubicin—Asthenia—Capecitabine—prostate cancer	6.13e-06	0.000164	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—prostate cancer	6.08e-06	0.000163	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—prostate cancer	6.07e-06	0.000162	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—prostate cancer	6.05e-06	0.000162	CcSEcCtD
Daunorubicin—Urticaria—Prednisone—prostate cancer	6.04e-06	0.000162	CcSEcCtD
Daunorubicin—Pruritus—Capecitabine—prostate cancer	6.04e-06	0.000162	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—prostate cancer	6.04e-06	0.000161	CcSEcCtD
Daunorubicin—Diarrhoea—Docetaxel—prostate cancer	6.03e-06	0.000161	CcSEcCtD
Daunorubicin—Abdominal pain—Prednisone—prostate cancer	6.01e-06	0.000161	CcSEcCtD
Daunorubicin—Body temperature increased—Prednisone—prostate cancer	6.01e-06	0.000161	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—prostate cancer	6e-06	0.00016	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—prostate cancer	5.96e-06	0.000159	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—prostate cancer	5.95e-06	0.000159	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—prostate cancer	5.95e-06	0.000159	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—prostate cancer	5.93e-06	0.000159	CcSEcCtD
Daunorubicin—Infection—Epirubicin—prostate cancer	5.91e-06	0.000158	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—prostate cancer	5.88e-06	0.000157	CcSEcCtD
Daunorubicin—Shock—Epirubicin—prostate cancer	5.85e-06	0.000157	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—prostate cancer	5.84e-06	0.000156	CcSEcCtD
Daunorubicin—Diarrhoea—Capecitabine—prostate cancer	5.84e-06	0.000156	CcSEcCtD
Daunorubicin—Dizziness—Docetaxel—prostate cancer	5.83e-06	0.000156	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—prostate cancer	5.82e-06	0.000156	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—prostate cancer	5.82e-06	0.000156	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—prostate cancer	5.8e-06	0.000155	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—prostate cancer	5.75e-06	0.000154	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—prostate cancer	5.74e-06	0.000154	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—prostate cancer	5.74e-06	0.000154	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—prostate cancer	5.74e-06	0.000154	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—prostate cancer	5.72e-06	0.000153	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—prostate cancer	5.67e-06	0.000152	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—prostate cancer	5.67e-06	0.000152	CcSEcCtD
Daunorubicin—Dizziness—Capecitabine—prostate cancer	5.65e-06	0.000151	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—prostate cancer	5.61e-06	0.00015	CcSEcCtD
Daunorubicin—Vomiting—Docetaxel—prostate cancer	5.61e-06	0.00015	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisone—prostate cancer	5.6e-06	0.00015	CcSEcCtD
Daunorubicin—Rash—Docetaxel—prostate cancer	5.56e-06	0.000149	CcSEcCtD
Daunorubicin—Dermatitis—Docetaxel—prostate cancer	5.55e-06	0.000149	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—prostate cancer	5.55e-06	0.000148	CcSEcCtD
Daunorubicin—Headache—Docetaxel—prostate cancer	5.52e-06	0.000148	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—prostate cancer	5.5e-06	0.000147	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—prostate cancer	5.5e-06	0.000147	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—prostate cancer	5.47e-06	0.000146	CcSEcCtD
Daunorubicin—Asthenia—Prednisone—prostate cancer	5.46e-06	0.000146	CcSEcCtD
Daunorubicin—Vomiting—Capecitabine—prostate cancer	5.43e-06	0.000145	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.42e-06	0.000145	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—prostate cancer	5.41e-06	0.000145	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—prostate cancer	5.39e-06	0.000144	CcSEcCtD
Daunorubicin—Rash—Capecitabine—prostate cancer	5.38e-06	0.000144	CcSEcCtD
Daunorubicin—Pruritus—Prednisone—prostate cancer	5.38e-06	0.000144	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—prostate cancer	5.38e-06	0.000144	CcSEcCtD
Daunorubicin—Dermatitis—Capecitabine—prostate cancer	5.38e-06	0.000144	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—prostate cancer	5.37e-06	0.000144	CcSEcCtD
Daunorubicin—Headache—Capecitabine—prostate cancer	5.35e-06	0.000143	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—prostate cancer	5.32e-06	0.000142	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—prostate cancer	5.3e-06	0.000142	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—prostate cancer	5.29e-06	0.000141	CcSEcCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisone—prostate cancer	5.25e-06	0.00775	CbGdCrCtD
Daunorubicin—Anorexia—Doxorubicin—prostate cancer	5.25e-06	0.00014	CcSEcCtD
Daunorubicin—Nausea—Docetaxel—prostate cancer	5.24e-06	0.00014	CcSEcCtD
Daunorubicin—Diarrhoea—Prednisone—prostate cancer	5.2e-06	0.000139	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—prostate cancer	5.17e-06	0.000138	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—prostate cancer	5.13e-06	0.000137	CcSEcCtD
Daunorubicin—Pain—Epirubicin—prostate cancer	5.09e-06	0.000136	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—prostate cancer	5.09e-06	0.000136	CcSEcCtD
Daunorubicin—Nausea—Capecitabine—prostate cancer	5.07e-06	0.000136	CcSEcCtD
Daunorubicin—Dizziness—Prednisone—prostate cancer	5.03e-06	0.000135	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.01e-06	0.000134	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—prostate cancer	4.98e-06	0.000133	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—prostate cancer	4.91e-06	0.000131	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—prostate cancer	4.9e-06	0.000131	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—prostate cancer	4.89e-06	0.000131	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—prostate cancer	4.86e-06	0.00013	CcSEcCtD
Daunorubicin—Vomiting—Prednisone—prostate cancer	4.84e-06	0.000129	CcSEcCtD
Daunorubicin—Rash—Prednisone—prostate cancer	4.8e-06	0.000128	CcSEcCtD
Daunorubicin—Dermatitis—Prednisone—prostate cancer	4.79e-06	0.000128	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—prostate cancer	4.78e-06	0.000128	CcSEcCtD
Daunorubicin—Headache—Prednisone—prostate cancer	4.76e-06	0.000127	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—prostate cancer	4.74e-06	0.000127	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—prostate cancer	4.73e-06	0.000126	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—prostate cancer	4.71e-06	0.000126	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—prostate cancer	4.71e-06	0.000126	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—prostate cancer	4.7e-06	0.000126	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—prostate cancer	4.7e-06	0.000126	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—prostate cancer	4.54e-06	0.000121	CcSEcCtD
Daunorubicin—Nausea—Prednisone—prostate cancer	4.52e-06	0.000121	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—prostate cancer	4.5e-06	0.00012	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—prostate cancer	4.38e-06	0.000117	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—prostate cancer	4.37e-06	0.000117	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—prostate cancer	4.35e-06	0.000116	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—prostate cancer	4.35e-06	0.000116	CcSEcCtD
Daunorubicin—Asthenia—Epirubicin—prostate cancer	4.27e-06	0.000114	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—prostate cancer	4.21e-06	0.000113	CcSEcCtD
Daunorubicin—Diarrhoea—Epirubicin—prostate cancer	4.07e-06	0.000109	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—prostate cancer	4.05e-06	0.000108	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—prostate cancer	3.95e-06	0.000106	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—prostate cancer	3.93e-06	0.000105	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—prostate cancer	3.89e-06	0.000104	CcSEcCtD
Daunorubicin—Vomiting—Epirubicin—prostate cancer	3.78e-06	0.000101	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—prostate cancer	3.77e-06	0.000101	CcSEcCtD
Daunorubicin—Rash—Epirubicin—prostate cancer	3.75e-06	0.0001	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—prostate cancer	3.75e-06	0.0001	CcSEcCtD
Daunorubicin—Headache—Epirubicin—prostate cancer	3.73e-06	9.97e-05	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—prostate cancer	3.64e-06	9.73e-05	CcSEcCtD
Daunorubicin—Nausea—Epirubicin—prostate cancer	3.53e-06	9.45e-05	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—prostate cancer	3.5e-06	9.36e-05	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—prostate cancer	3.47e-06	9.28e-05	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—prostate cancer	3.47e-06	9.27e-05	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—prostate cancer	3.45e-06	9.22e-05	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—prostate cancer	3.27e-06	8.74e-05	CcSEcCtD
Daunorubicin—CYP1A1—Metabolism—RXRA—prostate cancer	4.43e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ITPR1—prostate cancer	4.42e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MED12—prostate cancer	4.41e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOA2—prostate cancer	4.41e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—prostate cancer	4.41e-07	1.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNG5—prostate cancer	4.38e-07	1.55e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CREBBP—prostate cancer	4.36e-07	1.54e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.36e-07	1.54e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.36e-07	1.54e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.31e-07	1.52e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—prostate cancer	4.28e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CG—prostate cancer	4.28e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CD—prostate cancer	4.27e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—COMT—prostate cancer	4.26e-07	1.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—prostate cancer	4.24e-07	1.5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CG—prostate cancer	4.23e-07	1.49e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOA3—prostate cancer	4.22e-07	1.49e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—prostate cancer	4.21e-07	1.49e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA4—prostate cancer	4.18e-07	1.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.18e-07	1.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMS—prostate cancer	4.18e-07	1.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ITPR1—prostate cancer	4.18e-07	1.47e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—prostate cancer	4.17e-07	1.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.15e-07	1.46e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CD—prostate cancer	4.13e-07	1.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—prostate cancer	4.13e-07	1.46e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP2E1—prostate cancer	4.11e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.11e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—prostate cancer	4.1e-07	1.45e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—EP300—prostate cancer	4.09e-07	1.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA2—prostate cancer	4.07e-07	1.44e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NQO1—prostate cancer	4.06e-07	1.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—LPL—prostate cancer	4.05e-07	1.43e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—INS—prostate cancer	4.05e-07	1.43e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NOS3—prostate cancer	4.04e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HPGDS—prostate cancer	4.02e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCG5—prostate cancer	4.02e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.02e-07	1.42e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—INS—prostate cancer	4.01e-07	1.41e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TH—prostate cancer	4.01e-07	1.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2C19—prostate cancer	4e-07	1.41e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CREBBP—prostate cancer	3.97e-07	1.4e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP3A4—prostate cancer	3.96e-07	1.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMS—prostate cancer	3.95e-07	1.39e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—prostate cancer	3.94e-07	1.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTA1—prostate cancer	3.93e-07	1.39e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CREBBP—prostate cancer	3.93e-07	1.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—prostate cancer	3.91e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ACHE—prostate cancer	3.9e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTT1—prostate cancer	3.9e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NOS3—prostate cancer	3.9e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—prostate cancer	3.9e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1B1—prostate cancer	3.9e-07	1.38e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.89e-07	1.37e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTO1—prostate cancer	3.89e-07	1.37e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAT2—prostate cancer	3.89e-07	1.37e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ERCC2—prostate cancer	3.88e-07	1.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.86e-07	1.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1A—prostate cancer	3.85e-07	1.36e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.84e-07	1.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—prostate cancer	3.84e-07	1.36e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—LPL—prostate cancer	3.83e-07	1.35e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GGT1—prostate cancer	3.77e-07	1.33e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CD—prostate cancer	3.76e-07	1.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.75e-07	1.33e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PRKACB—prostate cancer	3.73e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CB—prostate cancer	3.73e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.73e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLCB2—prostate cancer	3.73e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LRP2—prostate cancer	3.73e-07	1.32e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CD—prostate cancer	3.72e-07	1.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOA1—prostate cancer	3.72e-07	1.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.7e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—prostate cancer	3.69e-07	1.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ERCC2—prostate cancer	3.67e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EP300—prostate cancer	3.67e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP19A1—prostate cancer	3.66e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—P4HB—prostate cancer	3.65e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—prostate cancer	3.65e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.64e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CB—prostate cancer	3.6e-07	1.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARA—prostate cancer	3.58e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—prostate cancer	3.57e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—prostate cancer	3.56e-07	1.26e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.55e-07	1.25e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NOS3—prostate cancer	3.55e-07	1.25e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—RXRA—prostate cancer	3.54e-07	1.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOA2—prostate cancer	3.52e-07	1.24e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NOS3—prostate cancer	3.51e-07	1.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.46e-07	1.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—prostate cancer	3.45e-07	1.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—prostate cancer	3.44e-07	1.21e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MED12—prostate cancer	3.41e-07	1.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—COMT—prostate cancer	3.41e-07	1.2e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—prostate cancer	3.39e-07	1.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARA—prostate cancer	3.38e-07	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNG5—prostate cancer	3.38e-07	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CAV1—prostate cancer	3.36e-07	1.19e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.36e-07	1.19e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—prostate cancer	3.35e-07	1.18e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ITPR1—prostate cancer	3.34e-07	1.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.28e-07	1.16e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CB—prostate cancer	3.28e-07	1.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA3—prostate cancer	3.26e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—prostate cancer	3.25e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NQO1—prostate cancer	3.24e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CB—prostate cancer	3.24e-07	1.15e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—prostate cancer	3.22e-07	1.14e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—prostate cancer	3.21e-07	1.13e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TH—prostate cancer	3.2e-07	1.13e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—prostate cancer	3.19e-07	1.13e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—prostate cancer	3.19e-07	1.12e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CAV1—prostate cancer	3.18e-07	1.12e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.18e-07	1.12e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.16e-07	1.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMS—prostate cancer	3.15e-07	1.11e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.15e-07	1.11e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—prostate cancer	3.12e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—prostate cancer	3.11e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—prostate cancer	3.11e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.11e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HPGDS—prostate cancer	3.11e-07	1.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.09e-07	1.09e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—EP300—prostate cancer	3.07e-07	1.08e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.06e-07	1.08e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LPL—prostate cancer	3.06e-07	1.08e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.04e-07	1.07e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—prostate cancer	3.02e-07	1.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTT1—prostate cancer	3.01e-07	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ACHE—prostate cancer	3.01e-07	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GGT1—prostate cancer	3.01e-07	1.06e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.98e-07	1.05e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—EP300—prostate cancer	2.97e-07	1.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOA1—prostate cancer	2.97e-07	1.05e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—prostate cancer	2.95e-07	1.04e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—prostate cancer	2.95e-07	1.04e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ERCC2—prostate cancer	2.93e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.92e-07	1.03e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—INS—prostate cancer	2.9e-07	1.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.9e-07	1.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CG—prostate cancer	2.9e-07	1.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PRKACB—prostate cancer	2.88e-07	1.02e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.85e-07	1.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CREBBP—prostate cancer	2.84e-07	1e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—prostate cancer	2.83e-07	1e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—RXRA—prostate cancer	2.82e-07	9.96e-06	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—prostate cancer	2.8e-07	9.9e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—prostate cancer	2.75e-07	9.72e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.74e-07	9.69e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—INS—prostate cancer	2.74e-07	9.68e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—COMT—prostate cancer	2.72e-07	9.6e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA2—prostate cancer	2.72e-07	9.59e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—prostate cancer	2.71e-07	9.57e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—prostate cancer	2.71e-07	9.55e-06	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—EP300—prostate cancer	2.7e-07	9.54e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARA—prostate cancer	2.7e-07	9.53e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.69e-07	9.51e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CREBBP—prostate cancer	2.68e-07	9.48e-06	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—EP300—prostate cancer	2.67e-07	9.44e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ITPR1—prostate cancer	2.66e-07	9.4e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.62e-07	9.24e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.59e-07	9.15e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CD—prostate cancer	2.55e-07	8.99e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NOS3—prostate cancer	2.54e-07	8.98e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CAV1—prostate cancer	2.54e-07	8.96e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.53e-07	8.94e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMS—prostate cancer	2.52e-07	8.88e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NQO1—prostate cancer	2.5e-07	8.84e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—prostate cancer	2.49e-07	8.78e-06	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—prostate cancer	2.47e-07	8.72e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TH—prostate cancer	2.47e-07	8.71e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LPL—prostate cancer	2.44e-07	8.62e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NOS3—prostate cancer	2.4e-07	8.49e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—prostate cancer	2.4e-07	8.48e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.4e-07	8.47e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.36e-07	8.32e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.35e-07	8.29e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ERCC2—prostate cancer	2.34e-07	8.25e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—prostate cancer	2.33e-07	8.22e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GGT1—prostate cancer	2.32e-07	8.21e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CG—prostate cancer	2.31e-07	8.16e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOA1—prostate cancer	2.29e-07	8.08e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—prostate cancer	2.27e-07	8.02e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.26e-07	7.97e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CB—prostate cancer	2.22e-07	7.83e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—prostate cancer	2.22e-07	7.82e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—prostate cancer	2.2e-07	7.76e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—prostate cancer	2.2e-07	7.76e-06	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—prostate cancer	2.2e-07	7.75e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—INS—prostate cancer	2.19e-07	7.73e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—RXRA—prostate cancer	2.18e-07	7.69e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARA—prostate cancer	2.16e-07	7.61e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CREBBP—prostate cancer	2.14e-07	7.57e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COMT—prostate cancer	2.1e-07	7.41e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—prostate cancer	2.09e-07	7.37e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ITPR1—prostate cancer	2.05e-07	7.25e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CD—prostate cancer	2.03e-07	7.18e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—prostate cancer	2.03e-07	7.16e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CAV1—prostate cancer	2.03e-07	7.16e-06	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—prostate cancer	2e-07	7.05e-06	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—prostate cancer	1.98e-07	6.98e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMS—prostate cancer	1.94e-07	6.85e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.94e-07	6.84e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—EP300—prostate cancer	1.94e-07	6.83e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NOS3—prostate cancer	1.92e-07	6.78e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—prostate cancer	1.92e-07	6.77e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—prostate cancer	1.92e-07	6.77e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LPL—prostate cancer	1.88e-07	6.65e-06	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—prostate cancer	1.86e-07	6.55e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.85e-07	6.52e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—EP300—prostate cancer	1.83e-07	6.45e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.82e-07	6.42e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ERCC2—prostate cancer	1.8e-07	6.37e-06	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—prostate cancer	1.79e-07	6.33e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CB—prostate cancer	1.77e-07	6.26e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—prostate cancer	1.76e-07	6.2e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—INS—prostate cancer	1.75e-07	6.17e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CREBBP—prostate cancer	1.71e-07	6.04e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—prostate cancer	1.7e-07	5.99e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARA—prostate cancer	1.66e-07	5.87e-06	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—prostate cancer	1.63e-07	5.76e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.62e-07	5.73e-06	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—prostate cancer	1.62e-07	5.7e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CAV1—prostate cancer	1.56e-07	5.52e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NOS3—prostate cancer	1.53e-07	5.41e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—prostate cancer	1.53e-07	5.41e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—EP300—prostate cancer	1.46e-07	5.16e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.43e-07	5.05e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.42e-07	5.03e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.41e-07	4.99e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—prostate cancer	1.4e-07	4.95e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.35e-07	4.78e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—INS—prostate cancer	1.35e-07	4.76e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CREBBP—prostate cancer	1.32e-07	4.66e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.25e-07	4.42e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—prostate cancer	1.22e-07	4.32e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NOS3—prostate cancer	1.18e-07	4.18e-06	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—prostate cancer	1.17e-07	4.13e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—EP300—prostate cancer	1.17e-07	4.12e-06	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—prostate cancer	1.1e-07	3.9e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.09e-07	3.85e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—prostate cancer	1.08e-07	3.82e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—prostate cancer	1.08e-07	3.81e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—prostate cancer	9.43e-08	3.33e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—EP300—prostate cancer	9e-08	3.18e-06	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—prostate cancer	8.83e-08	3.12e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.62e-08	3.04e-06	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—prostate cancer	7.05e-08	2.49e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.66e-08	2.35e-06	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—prostate cancer	5.44e-08	1.92e-06	CbGpPWpGaD
